New drug improves walking performance for Duchenne muscular dystrophy patients
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production ...
Aug 8, 2013